{"id":"CHEMBL1014","canonicalSmiles":"CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1","inchiKey":"GHOSNRCGJFBJIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CANDESARTAN CILEXETIL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amias","Atacand","Candesartan cilexetil","Ratacand"],"synonyms":["Candesartan","Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester","Candesartan cilexetil","TCV-116"],"crossReferences":{"DailyMed":["candesartan%20cilexetil"],"PubChem":["144212519","26748952"],"drugbank":["DB00796"],"chEBI":["3348"]},"count":17,"approvedIndications":["EFO_0003144","EFO_0000373","EFO_0000319","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["HP_0003124","HP_0000093","EFO_0000401","EFO_0001645","MONDO_0007254","EFO_0000373","EFO_0000319","EFO_0003774","EFO_1001496","EFO_0003843","EFO_0000537","EFO_0003913","EFO_1001153","EFO_0003914","EFO_1001150","EFO_0003144","EFO_0000712","EFO_0001359","EFO_1002032","EFO_0001360","EFO_0000400","HP_0001653"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL103043","canonicalSmiles":"N=C(N)c1ccc2cccc(Nc3ncccn3)c2c1","inchiKey":"GRQLDCHTDNYVQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL103043","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04059"],"chEBI":["46311"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL104166","canonicalSmiles":"N=C(N)c1ccc2cc(C(=O)Nc3ccc(CN)cc3)cc(Nc3ncccn3)c2c1","inchiKey":"CSWQJKHBMACTGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL104166","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108541","canonicalSmiles":"O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1","inchiKey":"OXNIZHLAWKMVMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRINITROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Picric acid","Trinitrophenol"],"crossReferences":{"Wikipedia":["Picric_acid"],"drugbank":["DB03651"],"chEBI":["46149"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1089318","canonicalSmiles":"Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1","inchiKey":"ASOADIZOVZTJSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPICAPONE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ongentys"],"synonyms":["BIA 9-1067","BIA-9-1067","BIA-91067","Ongentys","Opicapone"],"crossReferences":{"DailyMed":["opicapone"],"drugbank":["DB11632"]},"count":1,"approvedIndications":["EFO_0002508"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for parkinson's disease."}
{"id":"CHEMBL1093059","canonicalSmiles":"CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1","inchiKey":"TXGZJQLMVSIZEI-UQMAOPSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARDOXOLONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Cyano-3,12-Dioxooleana-1,9(11)-Dien-28-Oic Acid","Bardoxolone","CDDO","RTA 401","RTA-401"],"crossReferences":{"PubChem":["531235"],"drugbank":["DB12651"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1123","canonicalSmiles":"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1","inchiKey":"CURUTKGFNZGFSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICYCLOMINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bentyl","Dicyclomine","Dicycloverine"],"crossReferences":{"DailyMed":["dicyclomine%20hydrochloride"],"PubChem":["11111098","11112188","144207120","170464896","50100226","50104289","90341021"],"Wikipedia":["Dicycloverine"],"drugbank":["DB00804"],"chEBI":["4514"]},"childChemblIds":["CHEMBL1200479"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL112797","canonicalSmiles":"CCCCP(=O)(O)CCCN","inchiKey":"ONNMDRQRSGKZCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SGS-742","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-36742","LU-AE-58479","SGS742","Sgs-742","Sgs742"],"crossReferences":{"drugbank":["DB05010"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL11298","canonicalSmiles":"N[C@@H](CO)C(=O)O","inchiKey":"MTCFGRXMJLQNBG-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-serine","NSC-118365","Serine"],"crossReferences":{"PubChem":["11111802","11113417","11113418"],"Wikipedia":["Serine"],"drugbank":["DB00133"],"chEBI":["17115"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1139","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\\CCCC(=O)O)C[C@@H]21","inchiKey":"KAQKFAOMNZTLHT-OZUDYXHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPOPROSTENOL","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ACT-385781A","Epoprostenol","Flolan","PG-I2","Pgi2","Pgx","Prostacyclin","Prostaglandin i2","Prostaglandin x","U-53,217","U-53217"],"crossReferences":{"DailyMed":["epoprostenol%20sodium"],"PubChem":["26754811","50112680"],"drugbank":["DB01240"],"chEBI":["15552"]},"childChemblIds":["CHEMBL962"],"count":7,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0003086","MONDO_0005149","EFO_0001361","EFO_0000713","MONDO_0100096","EFO_0002687","EFO_0003144","EFO_0003827","EFO_0000319","HP_0004419","MONDO_0043510","EFO_0001360"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for recurrent thrombophlebitis and has 6 investigational indications."}
{"id":"CHEMBL116943","canonicalSmiles":"C1CCc2nnnn2CC1","inchiKey":"CWRVKFFCRWGWCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTYLENETETRAZOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cardiazol"],"synonyms":["NSC-5729","NSC-66489","Pentamethylenetetrazol","Pentetrazol","Pentylenetetrazol","Pentylenetetrazole"],"crossReferences":{"PubChem":["11111647","11111648","124881152","26747621","50106807","90341004"],"Wikipedia":["Pentylenetetrazol"],"drugbank":["DB13415"],"chEBI":["34910"]},"childChemblIds":["CHEMBL350551"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1172928","canonicalSmiles":"C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1","inchiKey":"RCOBKSKAZMVBHT-TVQRCGJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADAFAXINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Radafaxine"],"crossReferences":{"Wikipedia":["Radafaxine"],"drugbank":["DB11790"]},"childChemblIds":["CHEMBL2107365"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1173462","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCCCCC(=O)O","inchiKey":"XEZVDURJDFGERA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICOSANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tricosanoic Acid"],"crossReferences":{"drugbank":["DB03500"],"chEBI":["42394"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1187833","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2","inchiKey":"FVTWTVQXNAJTQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMECLIDINIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GSK-573719","GSK573719","Umeclidinium"],"crossReferences":{"DailyMed":["umeclidinium%20bromide"],"drugbank":["DB09076"]},"childChemblIds":["CHEMBL523299"],"count":3,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","HP_0000975","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 investigational indications."}
{"id":"CHEMBL1189150","canonicalSmiles":"N=c1c[n+](N2CCOCC2)[n-]o1","inchiKey":"FKDHHVKWGRFRTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINSIDOMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Linsidomine"],"crossReferences":{"PubChem":["11111414","90340687"],"drugbank":["DB13400"]},"childChemblIds":["CHEMBL538104"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200402","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=S(=O)(O)c1ccccc1","inchiKey":"ZPBWCRDSRKPIDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMLODIPINE BESYLATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1491","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amlodipine besylate","Norvasc"],"synonyms":["Amlodipine benzenesulfonate","Amlodipine besilate","Amlodipine besylate","UK-48,340-26","UK-48340-26"],"crossReferences":{"DailyMed":["amlodipine%20besylate"],"PubChem":["144205078","144207025","26749852"],"chEBI":["2669"]},"count":12,"approvedIndications":["HP_0003124","EFO_0000712","EFO_1000013","EFO_0000373","EFO_0003774","EFO_0000612","EFO_0004911","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["HP_0003124","HP_0000093","EFO_0001645","EFO_1000013","EFO_0000373","EFO_0003774","EFO_0004911","EFO_0000537","EFO_0003913","Orphanet_79292","EFO_0000712","EFO_1002032","EFO_0000612","EFO_0000668"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 9 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200737","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"KILNVBDSWZSGLL-KXQOOQHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLFOSCERIL PALMITATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["129Y83","Colfosceril palmitate"],"crossReferences":{"PubChem":["144206116","8139918"],"Wikipedia":["Colfosceril_palmitate"],"drugbank":["DB09114"],"chEBI":["72999"]},"count":2,"approvedIndications":["EFO_0000684","EFO_1000644"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for newborn respiratory distress syndrome and respiratory system disease."}
{"id":"CHEMBL1200778","canonicalSmiles":"C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1.Cl","inchiKey":"BIFMNMPSIYHKDN-FJXQXJEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXRAZOXANE HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1738","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexrazoxane hydrochloride","Totect","Zinecard"],"synonyms":["ADR-529 HYDROCHLORIDE","Dexrazoxane hydrochloride","ICRF-187 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["dexrazoxane%20hydrochloride"],"chEBI":["50224"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 10 investigational indications."}
{"id":"CHEMBL1200789","canonicalSmiles":"O=P([O-])(O)OCC(Cl)(Cl)Cl.[Na+]","inchiKey":"WFKJEZKHPGDCRK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOFOS SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201317","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Triclos"],"synonyms":["SCH 10159","SCH-10159","Trichloroethyl phosphate sodium","Triclofos sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200935","canonicalSmiles":"Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1","inchiKey":"UQAVIASOPREUIT-VQIWEWKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARIFENACIN HYDROBROMIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1346","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Darifenacin hydrobromide","Emselex","Enablex"],"synonyms":["Darifenacin hydrobromide","UK-88525-04 (HYDROBROMIDE)"],"crossReferences":{"DailyMed":["darifenacin%20hydrobromide"],"PubChem":["144206189","170465079"],"chEBI":["31455"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004."}
{"id":"CHEMBL1201014","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"VJZLQIPZNBPASX-OJJGEMKLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE SODIUM PHOSPHATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201231","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Codelsol","Cortisate","Hydeltrasol","Inflamase","Inflamase forte","Inflamase mild","Metreton","Orapred","Orapred odt","Pediapred","Predair","Predair forte","Prednisolone sodium phosphate","Predsol","Predsol-n"],"synonyms":["Prednisolone 21-disodium phosphate","Prednisolone sodium phosphate"],"crossReferences":{"DailyMed":["prednisolone%20sodium%20phosphate"]},"count":8,"approvedIndications":["EFO_0000270","EFO_0000768","EFO_0000341","EFO_0007141"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000270","EFO_0000768","EFO_0007126","EFO_0003929","EFO_0007141","EFO_0000341","EFO_0007415"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL1201063","canonicalSmiles":"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl","inchiKey":"XWIHRGFIPXWGEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPAFENONE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL631","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arythmol","Propafenone hydrochloride","Rythmol","Rythmol sr","Rytmonorm"],"synonyms":["Propafenone hydrochloride"],"crossReferences":{"DailyMed":["propafenone%20hydrochloride"],"PubChem":["26747617","26747618","50106779","50106780","50106781","56422489","855997"],"chEBI":["8466"]},"count":2,"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000168356","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169252","ENSG00000169432","ENSG00000043591","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":12},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201161","canonicalSmiles":"CC(=O)O.NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"UILOTUUZKGTYFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAFENIDE ACETATE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL419","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mafenide acetate","Sulfamylon"],"synonyms":["Mafenide acetate"],"crossReferences":{"DailyMed":["mafenide%20acetate"],"PubChem":["855706"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and has 1 investigational indication."}
{"id":"CHEMBL1201229","canonicalSmiles":"CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1","inchiKey":"RWZVPVOZTJJMNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECARIUM","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Demecarium"],"crossReferences":{"drugbank":["DB00944"],"chEBI":["59719"]},"childChemblIds":["CHEMBL1200514"],"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for glaucoma."}
{"id":"CHEMBL1201380","name":"CHEMBL1201380","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00223"]}}
{"id":"CHEMBL1201631","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrezza","Exubera","Humulin","Humulin br","Humulin r","Humulin r kwikpen","Humulin r pen","Ins humulin r","Insuman infusat","Myxredlin","Novolin","Novolin r","Velosulin","Velosulin br","Velosulin br human"],"synonyms":["INSULIN BOVINE INSULIN","Insulin","Insulin (human)","Insulin Recombinant Human","Insulin bovine","Insulin human","Insulin human (biosynthesis)","Insulin human (synthesis)","Insulin human semisynthetic","Insulin recombinant human","Insulin recombinant purified human"],"crossReferences":{"DailyMed":["insulin%20human","insulin%20recombinant%20human"],"DrugCentral":["5003"]},"count":41,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0006834","MONDO_0002009","EFO_0003095","EFO_0000401","HP_0002153","EFO_0003768","EFO_0000373","EFO_0003774","EFO_0009267","MONDO_0018555","EFO_1001951","EFO_0003914","EFO_1000783","EFO_1000653","MONDO_0002146","EFO_0004593","EFO_0000289","HP_0100543","EFO_0000712","EFO_0003884","EFO_0004143","EFO_0003917","EFO_0000400","EFO_0000692","HP_0000842","HP_0002140","HP_0003124","EFO_0002508","EFO_0001645","HP_0001919","HP_0011015","EFO_0003929","EFO_0009516","EFO_0001358","EFO_0001073","EFO_0003843","EFO_0000537","HP_0100806","EFO_1001050","EFO_0003840","MONDO_0100096","EFO_0007430","EFO_1000985","EFO_0002614","EFO_0001359","HP_0003074","EFO_0008583","EFO_0000341","EFO_0000612","HP_0001943","EFO_0000516","EFO_0001360","EFO_0005411","EFO_0005672"],"count":54},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 39 investigational indications."}
{"id":"CHEMBL1201658","drugType":"Small molecule","blackBoxWarning":false,"name":"ALKAVERVIR","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Veriloid"],"synonyms":["Alkavervir"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1207366","canonicalSmiles":"O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1","inchiKey":"XDKRVNKVAKCFGW-FOCLMDBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW468816","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW468816","Gw468816"],"childChemblIds":["CHEMBL400007"],"count":1,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003768"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1210221","canonicalSmiles":"CCCCC/C=C/C=C1\\C(=O)C=C[C@@H]1C/C=C/CCCC(=O)O","inchiKey":"VHRUMKCAEVRUBK-XOVNXQNQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1210221","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08435"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1224","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1","inchiKey":"PWACSDKDOHSSQD-IUTFFREVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACRIVASTINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benadryl allgy relief plus decongest","Semprex"],"synonyms":["Acrivastine","BW 825C","BW-825C"],"crossReferences":{"PubChem":["144206566"],"Wikipedia":["Acrivastine"],"drugbank":["DB09488"],"chEBI":["83168"]},"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994 and is indicated for allergy."}
{"id":"CHEMBL1230134","canonicalSmiles":"COc1ccc(-n2cnc3ccc(-c4n[nH]c(=S)o4)cc32)cc1","inchiKey":"QBVJMUOTMRYUKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230134","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230604","canonicalSmiles":"COc1ccc(-c2c(S(C)(=O)=O)ccc(C(=O)c3cnn(C(C)(C)C)c3O)c2C)cc1","inchiKey":"AVFXBZIGDFPGBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230604","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02850"],"chEBI":["40290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231557","canonicalSmiles":"Cc1cccc2c1C(=O)N(c1ccc(C#N)cc1)C2=O","inchiKey":"MVYDBJXCIFMINH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231557","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232131","canonicalSmiles":"O=S(=O)(O)c1cc(O)ccc1O","inchiKey":"IKQCSJBQLWJEPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOBESILIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13529"],"chEBI":["71157"]},"childChemblIds":["CHEMBL2106191","CHEMBL1514715","CHEMBL1707052"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1233001","canonicalSmiles":"C[C@H]1O[C@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(N)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LQEBEXMHBLQMDB-GDJBGNAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02547"],"chEBI":["17661"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234886","canonicalSmiles":"O=O","inchiKey":"MYMOFIZGZYHOMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYGEN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-948","E948","INS NO.948","INS-948","Oxygen","Oxygen 93 percent","RNS-60 COMPONENT OXYGEN","RNS60 COMPONENT OXYGEN"],"crossReferences":{"drugbank":["DB09140"],"chEBI":["15379"]},"count":64,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 64 investigational indications."}
{"id":"CHEMBL1235351","canonicalSmiles":"O=C(O)CCCCCC(=O)O","inchiKey":"WLJVNTCWHIRURA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMELIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pimelic acid"],"crossReferences":{"PubChem":["144208369"],"drugbank":["DB01856"],"chEBI":["30531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235353","canonicalSmiles":"Cc1ncc(COP(=O)(O)O)c(CN)c1O","inchiKey":"ZMJGSOSNSPKHNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAMINE PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206246","50125780"],"drugbank":["DB02142"],"chEBI":["18335"]},"childChemblIds":["CHEMBL3989779"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235421","canonicalSmiles":"O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2","inchiKey":"MMXZSJMASHPLLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROLOQUINOLINE QUINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03205"],"chEBI":["18315"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236003","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)CP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"KJNLSEOJEFDELT-JJNLEZRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE PHOSPHONOACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-O-Phosphonylacetyladenosine"],"crossReferences":{"drugbank":["DB02607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236345","canonicalSmiles":"Cc1c([N+](=O)[O-])cc([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"SPSSULHKWOKEEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRINITROTOLUENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4,6-Trinitrotoluene"],"crossReferences":{"Wikipedia":["Trinitrotoluene"],"drugbank":["DB01676"],"chEBI":["46053"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL124493","canonicalSmiles":"C[C@](O)(COc1c(F)c(F)c(F)c(F)c1F)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"MMNRWNREMUMYQG-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL124493","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254990","canonicalSmiles":"C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QYYDXDSPYPOWRO-JHMCBHKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORUCHOLIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norucholic acid","Norursodeoxycholic acid"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1276310","canonicalSmiles":"CO[C@@]1(NC(=O)C(C(=O)O)c2ccsc2)C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@@H]21","inchiKey":"BVCKFLJARNKCSS-DWPRYXJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMOCILLIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL 17421 FREE ACID","BRL 17421 [AS SODIUM]","BRL-17421","BRL-17421 FREE ACID","Temocillin"],"crossReferences":{"drugbank":["DB12343"],"chEBI":["51817"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL129788","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1OCCCOc1cc(Cl)c(Cl)cc1Cl","inchiKey":"MJZJYWCQPMNPRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WR-99210","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WR-99210"],"crossReferences":{"drugbank":["DB08734"]},"childChemblIds":["CHEMBL545921"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1314","canonicalSmiles":"CC(S)C(=O)NCC(=O)O","inchiKey":"YTGJWQPHMWSCST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOPRONIN","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acadione","Captimer","Thiola","Thiola ec","Tiopronin"],"synonyms":["Tiopronin"],"crossReferences":{"DailyMed":["tiopronin"],"PubChem":["144205207","170465217","29215361"],"TG-GATEs":["104"],"Wikipedia":["Tiopronin"],"drugbank":["DB06823"],"chEBI":["32229"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 2 investigational indications."}
{"id":"CHEMBL1377575","canonicalSmiles":"CC1CC(OC(=O)c2ccccc2O)CC(C)(C)C1","inchiKey":"WSSJONWNBBTCMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMOSALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Heliophan"],"synonyms":["Homomenthyl salicylate","Homosalate"],"crossReferences":{"PubChem":["144204725","144209307","144213399","170465478","17389300","26747404"],"drugbank":["DB11064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1398126","canonicalSmiles":"Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N.O.O","inchiKey":"LTKVFMLMEYCWMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMILORIDE HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL945","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amilamont","Amiloride hydrochloride","Amilospare 5","Amoride","Berkamil","Midamor"],"synonyms":["Amiloride hydrochloride","Amiloride hydrochloride dihydrate","Amipramidine"],"crossReferences":{"DailyMed":["amiloride%20hydrochloride"],"PubChem":["11113002"],"chEBI":["2640"]},"count":4,"approvedIndications":["EFO_0004269","EFO_0000373","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000111319"],"count":1},"linkedDiseases":{"rows":["EFO_0004269","Orphanet_586","EFO_0000373","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL139835","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"UWFYSQMTEOIJJG-FDTZYFLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROTERONE ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Androcur","Androcur 10","Cyprostat","Diane"],"synonyms":["Cyproterone","Cyproterone acetate","NSC-81430","SH 714","SH-714"],"crossReferences":{"PubChem":["144204615","144208884","144213258","170465682","17389953","26752883","46500455","49737417","90340797"],"drugbank":["DB04839"],"chEBI":["50743"]},"count":7,"linkedTargets":{"rows":["ENSG00000082175","ENSG00000113580","ENSG00000169083"],"count":3},"linkedDiseases":{"rows":["EFO_0001065","EFO_0000673","HP_0031217","EFO_0003894","EFO_0009867","MONDO_0008315","EFO_0000660","EFO_0003922"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1474963","canonicalSmiles":"CCc1oc2ccccc2c1C(=O)c1ccc(O)cc1","inchiKey":"RFRXIWQYSOIBDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZARONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hepatotoxicity"],"year":1992},"tradeNames":[],"synonyms":["Benzarone","L 2197"],"crossReferences":{"PubChem":["24424590"],"chEBI":["34559"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1992 due to Hepatotoxicity."}
{"id":"CHEMBL1480987","canonicalSmiles":"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1","inchiKey":"WZHCOOQXZCIUNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLANDELATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclobral","Cyclospasmol"],"synonyms":["Cyclandelate"],"crossReferences":{"PubChem":["144205278","29215478"],"drugbank":["DB04838"],"chEBI":["3988"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1575","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"FRPJXPJMRWBBIH-RBRWEJTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRAMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estramustine","NSC-89201","RO 22-2296/000","RO-22-2296000","RO-222296000"],"crossReferences":{"PubChem":["144205760","170466403","26758003","396503"],"Wikipedia":["Estramustine"],"drugbank":["DB01196"],"chEBI":["4868"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1594","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O","inchiKey":"GHOKWGTUZJEAQD-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTOTHENIC ACID","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calc pantoth","Cantopal","Pantothenic Acid","Vitamin B 5"],"synonyms":["Pantothenic acid","Pantothenic acid "],"crossReferences":{"Wikipedia":["Pantothenic_acid"],"drugbank":["DB01783"],"chEBI":["46905"]},"childChemblIds":["CHEMBL1901349"],"count":2,"approvedIndications":["EFO_0003884"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for chronic kidney disease and has 1 investigational indication."}
{"id":"CHEMBL1619758","canonicalSmiles":"CCC(N)Cc1c[nH]c2ccccc12","inchiKey":"ZXUMUPVQYAFTLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etryptamine"],"crossReferences":{"PubChem":["104171412","144206171"],"drugbank":["DB01546"]},"childChemblIds":["CHEMBL1412355"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628504","canonicalSmiles":"Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1.Cl","inchiKey":"KZVVGZKAVZUACK-BJILWQEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILPIVIRINE HYDROCHLORIDE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL175691","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edurant"],"synonyms":["Rilpivirine hydrochloride","TMC278 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["rilpivirine%20hydrochloride"],"chEBI":["68602"]},"count":1,"approvedIndications":["EFO_0000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for hiv infection."}
{"id":"CHEMBL168634","canonicalSmiles":"Cc1ccc(S(=O)(=O)N2N=Cc3ccccc3B2O)cc1","inchiKey":"UQIDNSKBUXCODH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL168634","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08265"],"chEBI":["83945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1689","canonicalSmiles":"Cl.c1ccc(CC2=NCCN2)cc1","inchiKey":"RHTNTTODYGNRSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLAZOLINE HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL770","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzidazol","Priscol","Priscoline"],"synonyms":["Benzazoline hydrochloride","TCMDC-125842","Tolazoline HCl","Tolazoline hydrochloride"],"crossReferences":{"PubChem":["144203890","14742771","170465219","26748277"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1689285","canonicalSmiles":"O=S([O-])O.[Na+]","inchiKey":"DWAQJAXMDSEUJJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BISULFITE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E222","Sodium bisulfite"],"crossReferences":{"Wikipedia":["Sodium_bisulfite"],"drugbank":["DB14015"],"chEBI":["26709"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697751","canonicalSmiles":"CC(C)Nc1ncccn1.O=P(O)(O)O","inchiKey":"CXEBHWXMQKIKPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAXONINE PHOSPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1740513","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1984},"tradeNames":[],"synonyms":["Isaxonine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1984 due to Hepatotoxicity."}
{"id":"CHEMBL1697766","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1","inchiKey":"WEYVCQFUGFRXOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perazine"],"crossReferences":{"PubChem":["144206523","29215456"],"drugbank":["DB12710"],"chEBI":["59118"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1707005","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.O","inchiKey":"AOFIMJMWPZOPAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1707005","maximumClinicalTrialPhase":0,"parentId":"CHEMBL682","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56320804","56463594"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742993","drugType":"Antibody","blackBoxWarning":false,"name":"BLOSOZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Blosozumab","LY-2541546","LY2541546"],"count":2,"linkedTargets":{"rows":["ENSG00000167941"],"count":1},"linkedDiseases":{"rows":["EFO_0003854","EFO_0003882"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743009","drugType":"Antibody","blackBoxWarning":false,"name":"EFUNGUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mycograb"],"synonyms":["Efungumab","HSP-90MAB","HSP90MAB","MYC-123","MYC-123A","MYC-123A MYC-123B MYC-124 HSP90MAB","MYC-123B","MYC-124","MYC123","MYC123A","MYC123B","MYC124"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743057","drugType":"Protein","blackBoxWarning":false,"name":"PEGSUNERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegsunercept","STNF-RI"],"count":1,"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1755","canonicalSmiles":"Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2","inchiKey":"IKENVDNFQMCRTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONIVAPTAN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Conivaptan"],"crossReferences":{"Wikipedia":["Conivaptan"],"drugbank":["DB00872"],"chEBI":["681850"]},"childChemblIds":["CHEMBL1201108"],"count":5,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148"],"count":2},"linkedDiseases":{"rows":["EFO_0001422","HP_0002902","EFO_0003144","EFO_0001421","EFO_0000319","MONDO_0043510"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL178090","canonicalSmiles":"NCc1ccc(-c2cccnc2)o1","inchiKey":"LENAVORGWBTPJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178090","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07621"],"chEBI":["41804"]},"childChemblIds":["CHEMBL4584258"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1818442","canonicalSmiles":"Cl.Clc1ccc([C@]23CNC[C@H]2C3)cc1Cl","inchiKey":"KAGBHVBIOJBGBD-NINOIYOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITIFADINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL592374","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amitifadine hydrochloride","DOV 21947","DOV-21,947 HYDROCHLORIDE","DOV-21947","DOV-21947 HYDROCHLORIDE","EB-1010","EB-1010 HYDROCHLORIDE"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL181936","canonicalSmiles":"C[C@@H]1c2cc(O)ccc2O[C@@H](c2ccc(OCCN3CCCC3)cc2)[C@H]1c1ccc(O)cc1","inchiKey":"XPVKGTWRXBSJKO-LHXLBICKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL181936","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07567"],"chEBI":["41593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1823241","canonicalSmiles":"O=C(CCCCCCCCC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314)Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"ALOIOAGKUOQNID-ITCIXCFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINALBUPHINE SEBACATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dinalbuphine sebacate","Nalbuphine sebacate","Naldebain"],"crossReferences":{"drugbank":["DB15341"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18850","canonicalSmiles":"O=C1CCCCC1","inchiKey":"JHIVVAPYMSGYDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXANONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclohexanone"],"crossReferences":{"PubChem":["144209319","144213067","17389954","56462788"],"Wikipedia":["Cyclohexanone"],"drugbank":["DB02060"],"chEBI":["17854"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1889041","canonicalSmiles":"CC(Cc1ccc(C(C)(C)C)cc1)CN1CCCCC1","inchiKey":"MGNFYQILYYYUBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPROPIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenpropidin","Patrol"],"crossReferences":{"PubChem":["29217960"],"drugbank":["DB12728"],"chEBI":["83291"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1892145","canonicalSmiles":"CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32","inchiKey":"WYJAPUKIYAZSEM-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINBURNINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vinburnine"],"crossReferences":{"PubChem":["144203611","170466205","457665","56463657"],"drugbank":["DB13793"],"chEBI":["4740"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1980391","canonicalSmiles":"COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2","inchiKey":"UOVCGJXDGOGOCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-1530","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-1530","RG-1530","Rg-1530"],"crossReferences":{"PubChem":["103905607"]},"count":1,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000066468","ENSG00000102755","ENSG00000037280","ENSG00000077782","ENSG00000113721","ENSG00000122025","ENSG00000142731"],"count":9},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL199237","canonicalSmiles":"O=C(NCc1ccccn1)c1ccc(Oc2ccccc2)cc1","inchiKey":"HVLSCZSVTCNAQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL199237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07459"],"chEBI":["41135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2013119","canonicalSmiles":"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)[O-])c2)c(OC)c1.[Na+]","inchiKey":"VLQLUZFVFXYXQE-USRGLUTNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RIGOSERTIB SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1241855","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Estybon"],"synonyms":["ON 01910 SODIUM","ON 01910.NA","ON-01910","ON-01910 SODIUM","ON-01910.NA","ON01910 SODIUM","On-01910.na","Rigosertib sodium","SYB C-1101"],"count":11,"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0009179","EFO_0000616","EFO_1001779","EFO_1000044","EFO_0000339","EFO_0000095","MONDO_0008170","EFO_0000222","EFO_0003811","EFO_0000311"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL203321","canonicalSmiles":"CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O","inchiKey":"WXJFKKQWPMNTIM-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRINCIDOFOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brincidofovir","CMX 001","CMX-001","CMX001","Hexadecyloxypropyl Cidofovir"],"crossReferences":{"drugbank":["DB12151"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2103793","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"QUWFSKKBMDKAHK-SBOJBMMISA-A","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"AGATOLIMOD SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2103792","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agatolimod sodium","Agatolimod tricosasodium salt","CPG 7909","CPG-7909","PF-03512676","PF-3512676"],"count":21,"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000616","EFO_0003869","MONDO_0019465","EFO_0007444","EFO_0000756","EFO_0000681","EFO_0002913","EFO_0000403","EFO_0000313","EFO_1001469","EFO_0005952","EFO_0003060","EFO_0000311","HP_0100806","EFO_0000096","EFO_0001068","EFO_0000095","MONDO_0000544","EFO_0000764","EFO_0000191","EFO_0000574","EFO_1001051","MONDO_0018906","EFO_1000550"],"count":25},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL2104398","canonicalSmiles":"OCC(O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"SERLAGPUMNYUCK-BLEZHGCXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOMALT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY I 3930","BAY-I-3930","E-953","INS NO.953","INS-953","Isomalt"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105039","canonicalSmiles":"c1ccc(CN(CCN2CCCC2)c2ccccc2)cc1","inchiKey":"MXHODDGKGSGCDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISTAPYRRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Histapyrrodine"],"crossReferences":{"drugbank":["DB13479"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105712","canonicalSmiles":"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"USNRYVNRPYXCSP-JUGPPOIOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFATINIB DIMALEATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1173655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilotrif"],"synonyms":["Afatinib dimaleate","Afatinib maleate","BIBW-2992 MA2","BIBW-2992-MA2","BIBW-2992MA2","BIBW2992 MA2","BIBW2992-MA2"],"crossReferences":{"DailyMed":["afatinib%20dimaleate"],"chEBI":["76003"]},"count":1,"approvedIndications":["EFO_0003060"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0001378","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL2105941","canonicalSmiles":"CCC1(CCC(C)C)C(=O)N=C([O-])NC1=O.[Na+]","inchiKey":"BNHGKKNINBGEQL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOBARBITAL SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL267894","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Amytal sodium","Sod amytal","Talamo"],"synonyms":["Amobarbital sodium","Amobarbital sodium for injection"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL2106418","canonicalSmiles":"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O=P(=O)O.O=P(=O)O.O=P(=O)O.O=P(=O)[O-].[Na+]","inchiKey":"CJYQQUPRURWLOW-YDLUHMIOSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE FOSFATEX","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB08","DMSC","Doxycycline fosfatex"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2106643","canonicalSmiles":"COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)[O-])C(=O)OC2.[Na+]","inchiKey":"DOZYTHNHLLSNIK-JOKMOOFLSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"MYCOPHENOLATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL866","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceptava","Myfortic"],"synonyms":["ERL 080","ERL-080","Mycophenolate sodium","Mycophenolic acid sodium salt","Mycophenolic sod","NSC-116072"],"crossReferences":{"chEBI":["67155"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106841","canonicalSmiles":"CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(C)(C)C=C2c1ccncc1","inchiKey":"YHUDSHIRWOVVCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL 4664","Brl-4664","Nonabine"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107376","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](C(C)C)N(C)C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C)C(C)C.Cl","inchiKey":"OOKIODJYZSVHDO-QMYFOHRPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TASIDOTIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111109","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ILX-651","ILX651","Tasidotin hydrochloride"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107820","canonicalSmiles":"COc1ccc(NC(=O)[C@H](CCCCN)NC(=O)c2cc(NC(=O)[C@H](CCCCN)NC(=O)c3cc(NC(=O)[C@H](CCCCN)NC(=O)c4cc(NC(=O)[C@@H](N)CCCCN)ccc4OC)ccc3OC)ccc2OC)cc1C(N)=O","inchiKey":"PWFIFNGOPQUNIT-ITMZJIMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELPARANTAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pmx 60056"],"synonyms":["Delparantag","PMX 60056","PMX-60056","Pmx-60056"],"crossReferences":{"drugbank":["DB12955"]},"childChemblIds":["CHEMBL2107828"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108080","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"PARNAPARIN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OP 21-23","OP-21-23","OP-2123","Parnaparin sodium"],"count":2,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108489","drugType":"Antibody","blackBoxWarning":false,"name":"KELIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-CE9.1","Keliximab","SB-210396"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108581","drugType":"Antibody","blackBoxWarning":false,"name":"CATUMAXOMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Removab"],"synonyms":["Catumaxomab"],"count":8,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000119888","ENSG00000167286","ENSG00000160654","ENSG00000198851"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003897","EFO_0000503","EFO_1001100","MONDO_0008170","EFO_1000251","EFO_0000313","EFO_0000311","HP_0001541"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and cancer and has 6 investigational indications."}
{"id":"CHEMBL2108628","drugType":"Small molecule","blackBoxWarning":false,"name":"PACLITAXEL POLIGLUMEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xyotax"],"synonyms":["CT-2103","PG-TXL","Paclitaxel conjugate with poly-l-glutamic acid","Paclitaxel poliglumex"],"count":14,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_1000253","EFO_0000616","EFO_0000466","MONDO_0008170","EFO_1000435","EFO_0005842","MONDO_0007254","MONDO_0002087","MONDO_0008315","EFO_0002917","EFO_0003060","EFO_0006772","EFO_1000357","EFO_0006462","MONDO_0002158","MONDO_0008903","EFO_0000673","EFO_0000707","EFO_0003833","EFO_1000042","EFO_1000494"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2108680","drugType":"Antibody","blackBoxWarning":false,"name":"PIDILIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ct-011"],"synonyms":["CT-011","Pidilizumab"],"count":9,"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1001480","EFO_0004220","EFO_0000756","EFO_0000681","EFO_0000182","EFO_0000403","EFO_0000673","EFO_0000574","EFO_0001378"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2109298","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-3617","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-3617","MEDI3617","Medi 3617","Medi-3617"],"count":2,"linkedTargets":{"rows":["ENSG00000091879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002617"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109520","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN M","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN M"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109653","drugType":"Antibody","blackBoxWarning":false,"name":"BERMEKIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xilonix"],"synonyms":[" RA-18C3","Bermekimab","CA-18C3","CV-18C3","MaBp1","Ra-18c3","T2-18C3"],"count":10,"linkedTargets":{"rows":["ENSG00000115008"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000365","EFO_1000710","EFO_0000676","HP_0000999","EFO_0000274","EFO_0001360","EFO_0000717","EFO_0003894","EFO_0000311"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2110912","canonicalSmiles":"O=C(OCCN1CCCCC1)C1(C2CCCCC2)CCCCC1","inchiKey":"MNSQDVCVWNXBFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHEXYVERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihexyverine"],"crossReferences":{"drugbank":["DB13678"]},"childChemblIds":["CHEMBL2106632"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL220428","canonicalSmiles":"Nc1ncccc1NCc1cc(-c2ccc3cc[nH]c3c2)ccc1OCc1ccccn1","inchiKey":"KMBPJSHPAXOXBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220428","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07994"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221886","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"URWAJWIAIPFPJE-YFMIWBNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SISOMICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 13475","Sisomicin","Sissomicin"],"crossReferences":{"drugbank":["DB12604"],"chEBI":["9169"]},"childChemblIds":["CHEMBL2146085","CHEMBL3989471"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL222649","canonicalSmiles":"CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1","inchiKey":"YUMYYTORLYHUFW-ZUDLOMHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL222649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222813","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"ARAIBEBZBOPLMB-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANAMIVIR","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relenza"],"synonyms":["GG-167","GG167","GR 121167X","GR-121167","GR-121167X","Relenza","Zanamivir"],"crossReferences":{"DailyMed":["zanamivir"],"PubChem":["144205743","170464662"],"Wikipedia":["Zanamivir"],"drugbank":["DB00558"],"chEBI":["50663"]},"childChemblIds":["CHEMBL3330707","CHEMBL57705","CHEMBL1673195"],"count":3,"approvedIndications":["EFO_0007328","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for viral disease and influenza and has 1 investigational indication."}
{"id":"CHEMBL2237108","canonicalSmiles":"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.Cl","inchiKey":"CAOOISJXWZMLBN-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOFLOXACIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL33","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233149","canonicalSmiles":"N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)cc3)o2)S1","inchiKey":"BKUMVXIXUVYKDQ-GHXNOFRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233149","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49815772"],"drugbank":["DB07534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2360580","canonicalSmiles":"CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1.Cl.Cl","inchiKey":"SDBHDSZKNVDKNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLIZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201271","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bucladin","Bucladin-s","Equivert"],"synonyms":["Buclizine hydrochloride","UCB 4445"],"crossReferences":{"PubChem":["144203574"],"chEBI":["61193"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2377050","canonicalSmiles":"[2H]C1([2H])Oc2ccc(S(=O)(=O)N(C[C@@]([2H])(O)[C@H](Cc3ccc(OC([2H])([2H])c4csc(C)n4)cc3)NC(=O)O[C@@]3([2H])CO[C@@]4([2H])OCC[C@@H]34)C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])cc2O1","inchiKey":"JORVRJNILJXMMG-IFIPRKHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2377050","maximumClinicalTrialPhase":0,"parentId":"CHEMBL206031","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL249736","canonicalSmiles":"c1ccc(-c2cc(NCc3cccnc3)n3ncc(C4CC4)c3n2)cc1","inchiKey":"CCDIUVLNHCGSMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL249736","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258921","canonicalSmiles":"O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21","inchiKey":"BELBBZDIHDAJOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOLSULFONPHTHALEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenol red","Phenolsulfonphthalein","Phenolsulphonphthalein","Phenosulfophthalein"],"crossReferences":{"PubChem":["144203563","144213875","170465805","4252556","75741"],"drugbank":["DB13212"],"chEBI":["31991"]},"childChemblIds":["CHEMBL3187327"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273386","canonicalSmiles":"O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1","inchiKey":"UFBJCMHMOXMLKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,4-DINITROPHENOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4-dinitrophenol","Dinitrophenol","MP-101","Mp-101","NSC-1532","SR-1C5"],"crossReferences":{"PubChem":["144208660","144210350","17389906","26747391","47193722"],"Wikipedia":["2,4-Dinitrophenol"],"drugbank":["DB04528"],"chEBI":["42017"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL278255","canonicalSmiles":"NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","inchiKey":"QGPKADBNRMWEQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLINAFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clinafloxacin"],"crossReferences":{"PubChem":["26658614"],"Wikipedia":["Clinafloxacin"],"drugbank":["DB14025"]},"childChemblIds":["CHEMBL537626"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278663","canonicalSmiles":"COc1ccc(CC(C)N)cc1","inchiKey":"NEGYEDYHPHMHGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARA-METHOXYAMPHETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["beta-methoxyamphetamine","para-Methoxyamphetamine"],"crossReferences":{"PubChem":["91153"],"Wikipedia":["Para-Methoxyamphetamine"],"drugbank":["DB01472"]},"childChemblIds":["CHEMBL536709"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305666","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CN1CCN(C)CC1)OCCO3","inchiKey":"RVFGKBWWUQOIOU-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LURTOTECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lurtotecan"],"crossReferences":{"Wikipedia":["Lurtotecan"],"drugbank":["DB12222"]},"childChemblIds":["CHEMBL341028","CHEMBL533140","CHEMBL2447951"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3137347","drugType":"Antibody","blackBoxWarning":false,"name":"VARLILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-1127","Varlilumab"],"count":7,"linkedTargets":{"rows":["ENSG00000139193"],"count":1},"linkedDiseases":{"rows":["EFO_0000630","EFO_0003863","EFO_0000756","EFO_0000681","EFO_0000574","EFO_0003060","EFO_0000519","EFO_0000632"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3185229","canonicalSmiles":"O.O.O.O.O.O.[Cl-].[Cl-].[Mg+2]","inchiKey":"DHRRIBDTHFBPNG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219642","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnogene"],"synonyms":["E-511","INS NO.511","INS-511","Magnesium chloride","Magnesium chloride hexahydrate","NSC-529832"],"crossReferences":{"DailyMed":["magnesium%20chloride"],"PubChem":["144207444"],"chEBI":["86345"]},"count":4,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 3 investigational indications."}
{"id":"CHEMBL3234237","canonicalSmiles":"Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F","inchiKey":"UVUYWJWYRLJHEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-37822681","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-37822681","Jnj-37822681"],"crossReferences":{"drugbank":["DB12579"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL326294","canonicalSmiles":"O=C1Nc2ccccc2C1=O","inchiKey":"JXDYKVIHCLTXOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isatin"],"crossReferences":{"PubChem":["144210074","47193744"],"Wikipedia":["Isatin"],"drugbank":["DB02095"],"chEBI":["27539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL33864","canonicalSmiles":"O=C(O)CCCCC1CCSS1","inchiKey":"AGBQKNBQESQNJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIPOIC ACID, ALPHA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thioctacid"],"synonyms":["Alpha lipoic acid","Lipoic acid, alpha","NSC-628502","NSC-90788","Thioctic acid","Thioctic acid dl-form"],"crossReferences":{"PubChem":["104171254","11532893","124881686","144203836","144209006","144213409","170465713","17388693","26747265","26752825","397475","50105475","57260117"],"chEBI":["16494"]},"count":23,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 23 investigational indications."}
{"id":"CHEMBL3407547","canonicalSmiles":"COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1","inchiKey":"ZZWWXIBKLBMSCS-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRSOCOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Firsocostat","GS-0976","GS-ACC","Gs-0976","ND-630"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL34124","canonicalSmiles":"COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2","inchiKey":"GHBCIXGRCZIPNQ-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLODANRIGAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMA-401","EMA401","Ema401","Olodanrigan","PD-126055"],"childChemblIds":["CHEMBL157510"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544994","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VOLANESORSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 304801","ISIS 304801 FREE ACID","ISIS-304801","Volanesorsen","free acid"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545161","drugType":"Small molecule","blackBoxWarning":false,"name":"LY545694","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-545694","LY545694","Ly545694"],"count":1,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","HP_0030839"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545239","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05019702","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRA-027","Pf-05019702","WAY-257027"],"count":1,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000731"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545264","canonicalSmiles":"CC(Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl","inchiKey":"GKJCVYLDJWTWQU-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2874455","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2874455","Ly-2874455"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_1001934"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545273","drugType":"Small molecule","blackBoxWarning":false,"name":"CR-3465","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cr-3465"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545418","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-779788","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-779788","XL-014","XL-652"],"count":1,"linkedTargets":{"rows":["ENSG00000131408"],"count":1},"linkedDiseases":{"rows":["EFO_0003914"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3586404","canonicalSmiles":"CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1","inchiKey":"UFKLYTOEMRFKAD-SHTZXODSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONATASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATG-008","CC-223","Cc-223","Onatasertib"],"crossReferences":{"drugbank":["DB12570"]},"count":7,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001901","EFO_0000182","EFO_0000403","MONDO_0007254","EFO_0001378","EFO_0003060","EFO_0000519"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL363387","canonicalSmiles":"O=C(O)Cn1cc(Cc2nc3c(F)c(F)cc(F)c3s2)c2ccccc21","inchiKey":"KYHVTMFADJNSGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIDORESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EML 676","EML-676","IDD 676","IDD-000676","IDD-000676-01","IDD-676","Lidorestat"],"crossReferences":{"drugbank":["DB07063"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707213","drugType":"Small molecule","blackBoxWarning":false,"name":"AUROTIOPROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aurotioprol"],"crossReferences":{"DrugCentral":["4767"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707285","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC HYDROXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferric hydroxide"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707350","canonicalSmiles":"C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1.CS(=O)(=O)O","inchiKey":"ALDUQYYVQWGTMR-GJFSDDNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAQUOTINIB MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3663929","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-8273 MESILATE","ASP-8273 MESYLATE","ASP8273 mesilate","Naquotinib mesilate","Naquotinib mesylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL379845","canonicalSmiles":"COC(=O)c1cccnc1","inchiKey":"YNBADRVTZLEFNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL NICOTINATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitathone"],"synonyms":["Methyl nicotinate"],"crossReferences":{"PubChem":["144205255","144212355","170465506","29215436"],"drugbank":["DB13882"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3827379","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(NCCN3CCS(=O)(=O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12","inchiKey":"XDMUFNNPLXHNKA-ZTESCHFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-955176","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-955176","Bms-955176","GSK-3532795"],"crossReferences":{"drugbank":["DB15193"]},"childChemblIds":["CHEMBL4159687"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833304","drugType":"Antibody","blackBoxWarning":false,"name":"TOSITUMOMAB 131I","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bexxar"],"synonyms":["Tositumomab (131I)","Tositumomab 131i","Tositumomab/iodine (131i) tositumomab"],"count":13,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0000873","MONDO_0019465","EFO_0000403","EFO_1001469","EFO_0005952","EFO_0000309","EFO_0003032","EFO_0000096","EFO_0000095","EFO_0000574","MONDO_0018906","EFO_0001378","EFO_0000183","EFO_1000550"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3916929","canonicalSmiles":"CNC(=O)C[C@H]1COc2cc(F)ccc2N1C(=O)c1ccc2c(c1)NC(=O)CO2","inchiKey":"MBKYLPOPYYLTNW-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-9977","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-9977","AZD9977","Azd 9977","Azd-9977","Azd9977"],"crossReferences":{"drugbank":["DB15418"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3926779","canonicalSmiles":"C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1.Cl","inchiKey":"WZRLNIOAVAFOOD-UZAUECDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3926779","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1963249","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL396416","canonicalSmiles":"N[C@@H](CSCC(=O)O)C(=O)O","inchiKey":"GBFLZEXEOZUWRN-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOCYSTEINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loviscol","Mucodyne","Mucodyne fte","Mucofan","Mucolex","Pulmoclase"],"synonyms":["AHR-3053","Carbocistein","Carbocisteine","Carbocysteine","L-carbocisteine","L-carbocysteine","LJ 206","LJ-206","NSC-14156","R05CB03"],"crossReferences":{"Wikipedia":["Carbocisteine"],"drugbank":["DB04339"],"chEBI":["16163"]},"childChemblIds":["CHEMBL4303635"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3989567","canonicalSmiles":"Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"ZVIYWUUZWWBNMB-VICXVTCVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXACILLIN SODIUM","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL819","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactocill","Cryptocillin","Oxacillin sodium","Prostaphlin"],"synonyms":["NSC-527712","Oxacillin sodium","Oxacillin sodium monohydrate","Oxacillin sodium salt monohydrate","P-12","SO 16,423","SQ 16,423","SQ-16423"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1971 and has 1 investigational indication."}
{"id":"CHEMBL4066936","canonicalSmiles":"COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N","inchiKey":"QZFHIXARHDBPBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERICIGUAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 1021189","BAY-1021189","MK-1242","Vericiguat"],"crossReferences":{"drugbank":["DB15456"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL419792","canonicalSmiles":"CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1","inchiKey":"RKZSNTNMEFVBDT-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUMANIROLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-95666E","Sumanirole"],"crossReferences":{"Wikipedia":["Sumanirole"],"drugbank":["DB06477"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL427216","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1","inchiKey":"BOVGTQGAOIONJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLICLAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bilxona","Dacadis mr","Diaglyk","Diamicron","Diamicron mr","Edicil","Glimil","Nazdol mr","Vamju","Vitile xl","Ziclaseg","Zicron","Zicron pr"],"synonyms":["Gliclazide","J3.151H","S-1702","S-852","SE 1702","SE-1702"],"crossReferences":{"PubChem":["144204141","170465698","26748918","26748919","26748920","49646130"],"Wikipedia":["Gliclazide"],"drugbank":["DB01120"],"chEBI":["31654"]},"count":3,"approvedIndications":["EFO_0000400"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL4285883","canonicalSmiles":"CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)[C@@H](OC(C)=O)C[C@]5(O)[C@@H]4CC[C@@H]3C2)O[C@@H](C)[C@@H]1O","inchiKey":"JLPDBLFIVFSOCC-XYXFTTADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEANDRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anvirzel","NSC-692219","Oleandrin"],"crossReferences":{"drugbank":["DB12843"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL429317","canonicalSmiles":"Cc1cc(/C(=C/Nc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)on1","inchiKey":"VMAKIACTLSBBIY-BOPFTXTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVL-3288","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anvylic-3288","Avl-3288","CCMI","UCI-4083","XY-4083"],"count":2,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0005411","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297206","canonicalSmiles":"F[Ag].N.N","inchiKey":"FJKGRAZQBBWYLG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SILVER DIAMMINE FLUORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300152","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diammine silver fluoride","Silver diamine fluoride","Silver diammine fluoride"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297255","canonicalSmiles":"COC(=O)C1(OC(=O)c2cncn2[C@H](C)c2ccccc2)CC1","inchiKey":"DRAFVCKNYNQOKR-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABP-700","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abp-700"],"crossReferences":{"drugbank":["DB15411"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297504","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/c1ccc(OCCN(C)C)cc1)CO2","inchiKey":"ZEZFKUBILQRZCK-MJSCXXSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELORANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beloranib","ZGN-433","ZGN-440","Zgn-433","Zgn-440"],"crossReferences":{"drugbank":["DB12671"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297587","canonicalSmiles":"Cc1[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N[C@H]1CCN(C(=O)N(C)C)C1","inchiKey":"KMIOJWCYOHBUJS-HAKPAVFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOROLANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vorolanib"],"crossReferences":{"drugbank":["DB15247"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297620","canonicalSmiles":"NC(=O)OC[C@H](N)Cc1ccccc1","inchiKey":"UCTRAOBQFUDCSR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLRIAMFETOL","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ADX-N-05","JZP-110","Jzp-110","R-228060","SKL-N-05","Solriamfetol","YKP-10A"],"crossReferences":{"DailyMed":["solriamfetol%20hydrochloride"],"drugbank":["DB14754"]},"childChemblIds":["CHEMBL4297212"],"count":4,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for attention deficit hyperactivity disorder and has 3 investigational indications."}
{"id":"CHEMBL4297865","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1","inchiKey":"UOFYSRZSLXWIQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIVERTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A610","AC-0010","AC0010","ACEA100610","Abivertinib","Ac0010","Avitinib","EX-ACEA0010"],"crossReferences":{"drugbank":["DB15327"]},"childChemblIds":["CHEMBL4297866"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297964","drugType":"Protein","blackBoxWarning":false,"name":"ACT-1 PEPTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Act-1 peptide","Granexin"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298108","drugType":"Enzyme","blackBoxWarning":false,"name":"BIFUNCTIONAL EPOXIDE HYDROLASE 2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifunctional epoxide hydrolase 2","Soluble epoxide hydrolase"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298110","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC MALTOL","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accrufer","Feraccru"],"synonyms":["Ferric maltol","ST-10","ST10","ST10-021","St10-021"],"count":2,"approvedIndications":["EFO_0004272","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for iron deficiency anemia and anemia (phenotype)."}
{"id":"CHEMBL4298127","drugType":"Unknown","blackBoxWarning":false,"name":"VRC-01LS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VRC-01LS","VRC01LS","Vrc-01ls","Vrc-hivmab080-00-ab","Vrc01ls"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298134","drugType":"Antibody","blackBoxWarning":false,"name":"OBEXELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Obexelimab","XMAB-5871","XMAB5871","Xmab5871"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4303345","canonicalSmiles":"Cl.O.O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O","inchiKey":"ARPUHYJMCVWYCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303345","maximumClinicalTrialPhase":0,"parentId":"CHEMBL8","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435883","canonicalSmiles":"CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)[O-])c3O[C@H]2C[C@H]1O.[Na+]","inchiKey":"YTCZZXIRLARSET-VJRSQJMHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BERAPROST SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1207745","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beraprost sodium","Beraprost sodium salt","MDL-201129","ML-1129","TRK-100","TRK-100STP"],"crossReferences":{"PubChem":["144206467"],"drugbank":["DB05229"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL447183","canonicalSmiles":"N#Cc1ccc(C(=O)N2CCC3(CC2)N=C(N)c2c(F)ccc(F)c2N3)cn1","inchiKey":"GIZYIOOBBUHOBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-C102222","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-C102222"],"crossReferences":{"drugbank":["DB07405"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452231","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O","inchiKey":"NRUKOCRGYNPUPR-QBPJDGROSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENIPOSIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vumon"],"synonyms":["NSC-122819","Teniposide","VM-26","VM26"],"crossReferences":{"drugbank":["DB00444"]},"count":4,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000220","EFO_0000574","MONDO_0003541"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for neoplasm and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL452461","canonicalSmiles":"O=c1c2c(c1=O)N(CCP(=O)(O)O)CCCN2","inchiKey":"BDABGOLMYNHHTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERZINFOTEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EAA-090","Perzinfotel"],"crossReferences":{"drugbank":["DB12365"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL452648","canonicalSmiles":"O=C(Nc1cc(Br)c(O)c(Br)c1)c1ccccc1","inchiKey":"HKODPZBPODONGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL452648","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459149","canonicalSmiles":"O=C([C@@H]1CCCN1C(=O)CCn1c(=O)c(-c2ccccc2)nc2ccccc21)N1CCCC1","inchiKey":"KWCKZIJGKMCYCI-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL459149","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594355","drugType":"Unknown","blackBoxWarning":false,"name":"APL-501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APL-501","Apl-501","CBT-501","GB-226","GB226","Gb226"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594395","canonicalSmiles":"O=C([O-])CCCO.[K+]","inchiKey":"TXSIWDVUJVMMKM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM OXYBATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Potassium oxybate"],"crossReferences":{"DailyMed":["potassium%20oxybate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL4594580","drugType":"Unknown","blackBoxWarning":false,"name":"NJH-395","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NJH-395","NJH395","Njh-395","Njh395"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460460","canonicalSmiles":"N#Cc1cnn(-c2ccc(Cl)cc2)c1N","inchiKey":"WIWSALMJHPGFDY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460460","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07291"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL491","canonicalSmiles":"CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"YPQLFJODEKMJEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYFLUTAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxyflutamide"],"crossReferences":{"PubChem":["144208402","144213961","17388977","174007324","56314870"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL500724","canonicalSmiles":"NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"ZVQZIVCQLFGXFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500724","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07256"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508102","canonicalSmiles":"CCOC(=O)n1ccn(C)c1=S","inchiKey":"CFOYWRHIYXMDOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIMAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neo-mercazole 20","Neo-mercazole 5"],"synonyms":["Athyromazole","Carbimazole"],"crossReferences":{"PubChem":["11112670","144204147","144212637","170465583","26749040"],"Wikipedia":["Carbimazole"],"drugbank":["DB00389"],"chEBI":["617099"]},"count":2,"approvedIndications":["HP_0000820"],"linkedTargets":{"rows":["ENSG00000115705"],"count":1},"linkedDiseases":{"rows":["EFO_0009190","HP_0000820"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for abnormality of the thyroid gland and has 1 investigational indication."}
{"id":"CHEMBL510038","canonicalSmiles":"Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1","inchiKey":"NQQBNZBOOHHVQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL510038","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15624"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL520613","canonicalSmiles":"Cc1c(CCO)sc[n+]1CCCCCCCCCCCC[n+]1csc(CCO)c1C.[Br-].[Br-]","inchiKey":"AFJCGBHHSKAACR-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBITIAZOLIUM BROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1183040","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albitiazolium bromide","SAR-97276A","SAR97276A","Sar97276a"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL522579","canonicalSmiles":"Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1","inchiKey":"UBVTVSINEVHYSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07811"],"chEBI":["90544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550453","canonicalSmiles":"O=C(CN1C[C@H](F)[C@@H](NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F","inchiKey":"SXIYSYYSKHUTQQ-RDJZCZTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL550453","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08143"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550795","canonicalSmiles":"O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1","inchiKey":"KSFDVNIKNYXUIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL550795","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08191"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL562668","canonicalSmiles":"CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1","inchiKey":"UNAZAADNBYXMIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTENABANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-945,598","CP-945598","CP-945598-01","Cp-945598","Otenabant","Otenabant hydrochloride"],"crossReferences":{"Wikipedia":["Otenabant"],"drugbank":["DB11745"]},"childChemblIds":["CHEMBL2103817","CHEMBL3526399"],"count":1,"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL570775","canonicalSmiles":"c1ccc(CNc2ccc(OC[C@H]3CCCN3)cc2)cc1","inchiKey":"HITMFLNAOQIZSN-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL570775","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07260"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58","canonicalSmiles":"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21","inchiKey":"KKZJGLLVHKMTCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOXANTRONE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mitoxantrone HCl","Novantrone"],"synonyms":["Mitoxantrone","NSC-279836","Novantrone"],"crossReferences":{"PubChem":["11111482","11111483","142727","162108252","50111146","85856281","90341083","92763439"],"Wikipedia":["Mitoxantrone"],"drugbank":["DB01204"],"chEBI":["50729"]},"childChemblIds":["CHEMBL1200827","CHEMBL1417019"],"count":9,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0000873","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_1001052","MONDO_0003541","EFO_0000565","EFO_0004251","EFO_0000339","MONDO_0019460","EFO_0004289","EFO_0000182","EFO_1001830","EFO_0000330","EFO_0000673","EFO_0000196","EFO_0000326","MONDO_0020743","EFO_0008522","EFO_0000198","EFO_0000616","EFO_0000220","MONDO_0019457","MONDO_0008170","EFO_0000403","EFO_0000222","EFO_0003929","EFO_1000286","EFO_0000224","MONDO_0008315","EFO_0003843","EFO_0001663","EFO_0000211","EFO_0003885","MONDO_0001023","EFO_0000095","MONDO_0019472","EFO_0000574","EFO_0004256","MONDO_0018906","EFO_0001378"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for neoplasm and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL597","canonicalSmiles":"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1","inchiKey":"MRBDMNSDAVCSSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTOLAMINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phentolamine"],"crossReferences":{"DailyMed":["phentolamine%20mesylate"],"PubChem":["104171285","11112200","124882050","124882053","144203915","170464866","26751465","26751466","26751467","50085867","50100389","50100390","50103967","860967","90341742"],"Wikipedia":["Phentolamine"],"drugbank":["DB00692"],"chEBI":["8081"]},"childChemblIds":["CHEMBL1204146","CHEMBL1200873"],"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0000319","HP_0001943","EFO_0001073","HP_0011499","MONDO_0008315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL66380","canonicalSmiles":"O=C(O)CNC(=O)NC1CCCCC1","inchiKey":"NVORCMBCUHQRDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(3-Cyclohexylureido)Acetic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(3-Cyclohexylureido)Acetic Acid"],"crossReferences":{"drugbank":["DB08256"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66907","canonicalSmiles":"NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)c(F)c2F)cc1","inchiKey":"AANTYZRUJFNZFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL66907","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL69330","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O","inchiKey":"VWFJDQUYCIWHTN-YFVJMOTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FARNESYL DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farnesyl Diphosphate"],"crossReferences":{"drugbank":["DB07780"],"chEBI":["17407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6993","canonicalSmiles":"Nc1nc2ccccc2c(=O)[nH]1","inchiKey":"SDTFBAXSPXZDKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6993","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03780"],"chEBI":["85558"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7010","canonicalSmiles":"CCNC1C2CCC(C2)C1c1ccccc1","inchiKey":"IKFBPFGUINLYQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENCAMFAMIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fencamfamin"],"crossReferences":{"Wikipedia":["Fencamfamine"],"drugbank":["DB01463"]},"childChemblIds":["CHEMBL2106270"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL715","canonicalSmiles":"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1","inchiKey":"KVWDHTXUZHCGIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLANZAPINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arkolamyl","Olanzapine","Zalasta","Zyprexa","Zyprexa zydis"],"synonyms":["LY-170053","LY170053","Olanzapine"],"crossReferences":{"DailyMed":["olanzapine","olanzapine%20pamoate"],"PubChem":["144205109","170465009","174006883","26719852","26750094","29215187","49666419"],"Wikipedia":["Olanzapine"],"drugbank":["DB00334"],"chEBI":["7735"]},"childChemblIds":["CHEMBL1201741","CHEMBL3989694"],"count":30,"approvedIndications":["EFO_0000289","MONDO_0002009","EFO_0003761","EFO_0005407","EFO_0000692","EFO_0005411","HP_0000713"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["EFO_0004566","EFO_0004280","MONDO_0002009","HP_0000726","EFO_0003847","HP_0001824","HP_0002018","EFO_0003829","MONDO_0001416","EFO_0004247","EFO_0000289","MONDO_0002050","HP_0002017","EFO_0003761","EFO_0009854","HP_0002013","HP_0012167","EFO_0000253","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0004215","EFO_0000616","EFO_0005203","EFO_0006911","HP_0012076","EFO_0000677","EFO_0003758","EFO_1000904","EFO_0009963","EFO_0005407","HP_0002315","HP_0000713","EFO_0003852","Orphanet_399","Orphanet_79292","EFO_0004888","EFO_0004699","EFO_0005411"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 7 approved and 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL729","canonicalSmiles":"Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O","inchiKey":"KJHKTHWMRKYKJE-SUGCFTRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOPINAVIR","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kaletra"],"synonyms":["A-157378-0","A-157378.0","ABT-378","Lopinavir"],"crossReferences":{"DailyMed":["lopinavir"],"PubChem":["124893167","144205757","170464773","26757998","50111692"],"Wikipedia":["Lopinavir"],"drugbank":["DB01601"],"chEBI":["31781"]},"count":10,"approvedIndications":["EFO_0000764","EFO_0000180"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for hiv infection and hiv-1 infection and has 8 investigational indications."}
{"id":"CHEMBL81421","canonicalSmiles":"Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"IELOKBJPULMYRW-NJQVLOCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-ALPHA-TOCOPHERYL SUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Tocopheryl Succinate"],"crossReferences":{"PubChem":["144206109","144207766","50112815"],"drugbank":["DB14001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL90","canonicalSmiles":"NCCc1c[nH]cn1","inchiKey":"NTYJJOPFIAHURM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HISTAMINE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Histamine","NSC-33792"],"crossReferences":{"PubChem":["104171171","11111275","124880328","144203717","170465001","26753351","26753352","8139979","90341171"],"Wikipedia":["Histamine"],"drugbank":["DB05381"],"chEBI":["18295"]},"childChemblIds":["CHEMBL1533310","CHEMBL544208","CHEMBL3989520","CHEMBL535166"],"count":10,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003821","EFO_0000222","EFO_0005952","EFO_0000565","EFO_0003885","MP_0001845","EFO_0005531","EFO_0000678","EFO_0000270","EFO_0000389","EFO_0004616","MONDO_0002367","MONDO_0003276","MONDO_0024880","EFO_0003956","EFO_0003785"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1939 and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL93268","canonicalSmiles":"O=N[O-].[Na+]","inchiKey":"LPXPTNMVRIOKMN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"SODIUM NITRITE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1161681","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sodium nitrite"],"synonyms":["E250","INS NO.250","INS-250","NSC-77391","Sodium Nitrite","Sodium nitrite"],"crossReferences":{"DailyMed":["sodium%20nitrite"],"DrugCentral":["4797"],"PubChem":["144209353","144210345","17388728","17389803"],"Wikipedia":["Sodium_nitrite"],"chEBI":["78870"]},"count":17,"approvedIndications":["EFO_0008546"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for poisoning and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL950","canonicalSmiles":"O=C(O)C(=O)c1ccccc1","inchiKey":"FAQJJMHZNSSFSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOYL FORMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoyl formic acid"],"crossReferences":{"drugbank":["DB02279"],"chEBI":["18280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL996","canonicalSmiles":"CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21","inchiKey":"WZOZEZRFJCJXNZ-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CEFOXITIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cenomycin","Mefoxin","Mefoxitin"],"synonyms":["Cefoxitin","J01DC01","Mefoxin"],"crossReferences":{"DailyMed":["cefoxitin%20sodium"],"PubChem":["144206560","170465105"],"Wikipedia":["Cefoxitin"],"drugbank":["DB01331"],"chEBI":["209807"]},"childChemblIds":["CHEMBL1200530"],"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for bacterial disease and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL9960","canonicalSmiles":"CC[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1","inchiKey":"MXNGYQJJYRVGGJ-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7624","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-7624","Azd 7624","Azd-7624"],"count":3,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000270","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
